• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱非肌层浸润性透明细胞癌:是否需要膀胱切除术?

Non-muscle-invasive clear cell carcinoma of the urinary bladder: Is cystectomy necessary?

作者信息

Jayawardhana Tamani, Alsayed Hossam, Goel Amit, Madaan Sanjeev

机构信息

Department of Urology & Nephrology, Darent Valley Hospital, Dartford, UK.

Department of Histopathology, Maidstone Hospital, Maidstone, UK.

出版信息

BMJ Case Rep. 2019 Mar 7;12(3):e226928. doi: 10.1136/bcr-2018-226928.

DOI:10.1136/bcr-2018-226928
PMID:30850563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6424185/
Abstract

We report the clinical presentation, histological findings and management of a 49-year-old female patient with non-muscle-invasive clear cell carcinoma of the urinary bladder. In the literature, there are only seven such case reports. We feel that transurethral resection of the bladder tumour followed by close cystoscopy surveillance is a suitable management for non-muscle-invasive clear cell carcinoma of the urinary bladder.

摘要

我们报告了一名49岁非肌层浸润性膀胱透明细胞癌女性患者的临床表现、组织学检查结果及治疗情况。在文献中,此类病例报告仅有7例。我们认为,经尿道膀胱肿瘤切除术,随后密切进行膀胱镜监测,是治疗非肌层浸润性膀胱透明细胞癌的合适方法。

相似文献

1
Non-muscle-invasive clear cell carcinoma of the urinary bladder: Is cystectomy necessary?膀胱非肌层浸润性透明细胞癌:是否需要膀胱切除术?
BMJ Case Rep. 2019 Mar 7;12(3):e226928. doi: 10.1136/bcr-2018-226928.
2
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
3
The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.在低危、非肌肉浸润性膀胱癌患者中,频繁膀胱镜检查对手术护理和癌症结果的影响。
Cancer. 2019 Sep 15;125(18):3147-3154. doi: 10.1002/cncr.32185. Epub 2019 May 23.
4
Safety and Efficacy of En Bloc Transurethral Resection With 1.9 µm Vela Laser for Treatment of Non-Muscle-invasive Bladder Cancer.1.9微米Vela激光整块经尿道切除术治疗非肌层浸润性膀胱癌的安全性和有效性
Urology. 2018 Mar;113:246-250. doi: 10.1016/j.urology.2017.11.030. Epub 2017 Dec 2.
5
The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.经尿道膀胱肿瘤切除术在非肌层浸润性膀胱癌治疗中的重要性:新技术的系统评价
J Urol. 2014 Jun;191(6):1655-64. doi: 10.1016/j.juro.2014.01.087. Epub 2014 Feb 8.
6
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2013 年更新版。
Eur Urol. 2013 Oct;64(4):639-53. doi: 10.1016/j.eururo.2013.06.003. Epub 2013 Jun 12.
7
Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.经尿道膀胱肿瘤切除术和根治性膀胱切除术配对标本中尿路上皮癌的淋巴管浸润情况。
J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.
8
Vesical clear cell adenocarcinoma of Müllerian origin treated conservatively with partial cystectomy.来源于苗勒管的膀胱透明细胞腺癌行部分膀胱切除术保守治疗。
BMJ Case Rep. 2022 Apr 5;15(4):e245015. doi: 10.1136/bcr-2021-245015.
9
Deceptive muscle invasive bladder cancer recurrence with benign biopsy foci after bladder sparing treatment.膀胱保留治疗后出现伴有良性活检灶的欺骗性肌层浸润性膀胱癌复发。
Medicine (Baltimore). 2015 Jun;94(22):e898. doi: 10.1097/MD.0000000000000898.
10
Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.在非肌肉浸润性膀胱癌中鉴别黏膜肌层浸润(T1a 与 T1b)的预后意义:法国全国多中心研究及中心病理复查。
J Urol. 2013 Jun;189(6):2069-76. doi: 10.1016/j.juro.2012.11.120. Epub 2012 Nov 28.

本文引用的文献

1
Primary Clear Cell Carcinoma of the Urinary Bladder.膀胱原发性透明细胞癌
Int Sch Res Notices. 2014 Jul 2;2014:593826. doi: 10.1155/2014/593826. eCollection 2014.
2
Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S.膀胱和尿道透明细胞腺癌:另一种对P504S呈免疫反应性的泌尿道病变。
Arch Pathol Lab Med. 2008 Sep;132(9):1417-22. doi: 10.5858/2008-132-1417-CCAOUB.
3
Clear cell carcinoma of the urinary bladder.膀胱透明细胞癌
Pathology. 2006 Aug;38(4):367-70. doi: 10.1080/00313020600820849.
4
Mesonephroid adenocarcinoma of the bladder and urethra: a case report.膀胱和尿道中肾样腺癌:一例报告
Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(1):47-9. doi: 10.1007/s001920200010.
5
Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.膀胱透明细胞癌:4例苗勒管起源肿瘤及9例可能为尿路上皮起源肿瘤的报告与比较,并讨论组织发生及诊断问题
Am J Surg Pathol. 2002 Feb;26(2):190-7. doi: 10.1097/00000478-200202000-00005.
6
The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature.下尿路透明细胞腺癌的组织发生。病例系列及文献综述。
Hum Pathol. 1996 Mar;27(3):248-52. doi: 10.1016/s0046-8177(96)90064-7.
7
Clear cell adenocarcinoma of the urinary bladder: report of a case of probable müllerian origin.膀胱透明细胞腺癌:一例可能起源于苗勒管的病例报告。
Mod Pathol. 1993 Mar;6(2):225-8.
8
Mesonephric adenocarcinoma of the bladder.
J Urol. 1968 Oct;100(4):466-9. doi: 10.1016/s0022-5347(17)62554-0.
9
Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature.膀胱和尿道透明细胞腺癌。三例报告并文献复习。
Am J Surg Pathol. 1985 Nov;9(11):816-26. doi: 10.1097/00000478-198511000-00005.